Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Ignite's Impact | Explore how Health Catalyst's new Ignite platform is driving sales momentum and reshaping the company's growth trajectory in the healthcare analytics market |
Financial Resilience | Health Catalyst outperformed Q2 2024 expectations, with revenue and EBITDA surpassing estimates, showcasing operational efficiency amid market challenges |
Market Dynamics | Delve into Health Catalyst's position in the evolving Healthcare IT sector, balancing innovation against cybersecurity concerns and hospital spending pressures |
Future Outlook | Analyst projections range from $8 to $14, reflecting varied perspectives on Health Catalyst's ability to capitalize on data-driven healthcare trends |
Metrics to compare | HCAT | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipHCATPeersSector | |
---|---|---|---|---|
P/E Ratio | −6.3x | −0.9x | −0.7x | |
PEG Ratio | −0.15 | 0.01 | 0.00 | |
Price/Book | 1.4x | 0.8x | 2.6x | |
Price / LTM Sales | 1.7x | 1.8x | 3.2x | |
Upside (Analyst Target) | 45.0% | 42.7% | 44.1% | |
Fair Value Upside | Unlock | 49.3% | 8.2% | Unlock |